美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
STAVUDINE; LAMIVUDINE; NEVIRAPINE	021837	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	40MG; 150MG; 200MG	No	No	2008/03/20 (TA)	--	STRIDES ARCOLAB	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022177	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	30MG; 150MG; 200MG	No	No	2008/03/20 (TA)	--	STRIDES ACROLAB	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	022061	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL	150MG; 200MG; 300MG	No	No	2008/10/21 (TA)	--	MATRIX LABS	None (Tentative Approval)
ABACAVIR SULFATE; LAMIVUDINE	022295	001	NDA	ABACAVIR SULFATE; LAMIVUDINE	TABLET; ORAL	60MG; 30MG	No	No	2008/12/19 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022346	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	30MG; 150MG; 200MG	No	No	2009/02/27 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022346	002	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	40MG; 150MG; 200MG	No	No	2009/02/27 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
LAMIVUDINE	090433	001	ANDA	LAMIVUDINE	TABLET; ORAL	150MG	No	No	2009/03/16 (TA)	--	ALKEM LABS LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE	022347	001	NDA	STAVUDINE; LAMIVUDINE	TABLET; ORAL	30MG; 150MG	No	No	2009/03/18 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE	022347	002	NDA	STAVUDINE; LAMIVUDINE	TABLET; ORAL	40MG; 150MG	No	No	2009/03/18 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
ABACAVIR SULFATE; LAMIVUDINE	090519	001	ANDA	ABACAVIR SULFATE; LAMIVUDINE	TABLET; ORAL	600MG; 300MG	No	No	2009/03/30 (TA)	--	MATRIX LABS LTD	None (Tentative Approval)
LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG	022356	001	NDA	LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE	TABLET; ORAL	150MG; 300MG; 200MG	No	No	2009/05/07 (TA)	--	HETERO DRUGS LTD	None (Tentative Approval)
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE	090309	001	ANDA	ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL	EQ 300MG BASE; 150MG; 300MG	No	No	2009/07/15 (TA)	--	MYLAN PHARMA	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022342	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	30MG; 150MG; 200MG	No	No	2009/07/16 (TA)	--	EMCURE PHARMA	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022342	002	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	40MG; 150MG; 200MG	No	No	2009/07/16 (TA)	--	EMCURE PHARMA	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	022296	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL	30MG; 60MG	No	No	2009/07/23 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE FDC TABS	022459	001	NDA	LAMIVUDINE; TENOFOVIR	TABLET; ORAL	300MG/300MG	No	No	2009/11/05 (TA)	--	HETERO DRUGS LTD	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	022464	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL	150MG; 200MG; 300MG	No	No	2009/12/22 (TA)	--	STRIDES ARCOLAB LTD	None (Tentative Approval)
LAMIVUDINE AND STAVUDINE	022479	001	NDA	LAMIVUDINE; STAVUDINE	TABLET; ORAL	150MG/30MG	No	No	2010/05/17 (TA)	--	HETERO DRUGS LTD	None (Tentative Approval)
LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS	200793	001	NDA	Lamivudine; Nevirapine; Zidovudine	TABLET, FOR SUSPENSION; ORAL	30MG; 50MG; 60MG	No	No	2010/07/08 (TA)	--	MATRIX LABS	None (Tentative Approval)
LAMIVUDINE AND STAVUDINE	022541	001	NDA	LAMIVUDINE; STAVUDINE	TABLET; ORAL	150MG; 30MG	No	No	2010/08/05 (TA)	--	MACLEODS PHARMA	None (Tentative Approval)